Looking Into Cushman & Wakefield’s Return On Capital Employed
According to Benzinga Pro, during Q1, Cushman & Wakefield (NYSE:CWK) earned $45.50 million, a 68.79% increase from the preceding quarter. Cushman & Wakefield's sales decreased to $1.70 billion, a 40.92% change since Q4.
Morgan Stanley Maintains Overweight on Cushman & Wakefield, Lowers Price Target to $22.5
Morgan Stanley analyst Richard Hill maintains Cushman & Wakefield (NYSE:CWK) with a Overweight and lowers the price target from $23 to $22.5.
Raymond James Maintains Strong Buy Rating for Cushman & Wakefield: Here’s What You Need To Know
Raymond James has decided to maintain its Strong Buy rating of Cushman & Wakefield (NYSE:CWK) and raise its price target from $32.00 to $35.00.
Shares of Cushman & Wakefield are trading up 4.48% over the last 24 hours, at $19.00 per share.
Where Cushman & Wakefield Stands With Analysts
Analysts have provided the following ratings for Cushman & Wakefield (NYSE:CWK) within the last quarter:
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Raymond James Maintains Strong Buy on Cushman & Wakefield, Lowers Price Target to $32
Raymond James analyst Patrick O'Shaughnessy maintains Cushman & Wakefield (NYSE:CWK) with a Strong Buy and lowers the price target from $38 to $32.
Expert Ratings for Cushman & Wakefield
Analysts have provided the following ratings for Cushman & Wakefield (NYSE:CWK) within the last quarter:
Morgan Stanley Maintains Overweight on Cushman & Wakefield, Lowers Price Target to $23
Morgan Stanley analyst Richard Hill maintains Cushman & Wakefield (NYSE:CWK) with a Overweight and lowers the price target from $25 to $23.
